Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Legal Address
304 Atlanta Arcade, Marol Church Road,Andheri East
Mumbai; Maharashtra; Map
Postal Code: 400059
Tel: +91-0226676
Fax: +91-0222821
Email: @macleodspharma.com

Full name: Macleods Pharmaceuticals Ltd

Status: Non-Listed
Legal Form: Limited Liability Company
Operational Status: Operational
EMISid: 2382646
IN-CIN: U24239MH1989PLC052049
Incorporation Date: 1989

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing | Scientific Research and Development Services

Main Products

finished drug products and Active Pharmaceutical ingredients

Company Description

Macleods Pharmaceuticals Ltd. engages in the manufacture of wide range of finished drug products and Active Pharmaceutical ingredients. The company specializes in the segments of Cardiovascular, Diabetes, Orthopedics, Gynecology, Respiratory and Oncology. Macleods Pharmaceuticals has facility to manufacture Tablets (dispersible, bi-layered, coated, uncoated, enteric coated), Hard gelatin capsules, Soft gelatin capsules, Dry powder injections, Dry syrups, Granules and Liquid Orals. Incorporated in 1989, the…

More

Basic Information

Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Export-Import

2010: Imports INR 891,847.20 Thousands
Import connections ('000)
Total(19,902.86)
2010: Exports INR 1,752,335.16 Thousands
Export connections ('000)
Total(39,105.90)

Key Executives

Director & Member
More

Ownership Details

Anju Agarwal
16.31%

Key Stats

Select Items to chart them. 2016 Y
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 37,809,700
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Individual
Source: Dion Global Solutions Limited, EMIS Company Database.

Financials

Competitors - India

INR | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2016
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest